Figure 1
Figure 1. Loss of the BH3-only protein Puma protects mast cells from apoptosis induced by cytokine deprivation. Survival of mast cells in the absence of cytokines was measured by staining with PI plus annexin V-FITC (A) MLMCs where ◇ indicates wild-type; ▵, Noxa−/−; ×, Bad−/−; and ○, Bid−/−. N = 4-12 (B) CTLMCs where ◇ indicates wild-type; ▵, Noxa−/−; ×, Bad−/−; ○, Bid−/−; and □, Bmf−/−. N = 2-6 (C) MLMCs where ◇ indicates wild-type; −, vav-Bcl2; ●, Puma−/−; ▴, Puma+/−. N = 6 (D) CTLMCs where ◇ indicates wild-type; −, vav-Bcl2; ●, Puma−/−; ▴, Puma+/−. N = 3-4 and results are presented as mean (± SD). (E) Expression of Puma was determined by Western blotting of lysates from wt MLMCs and CTLMCs following cytokine deprivation for 10 hours. Probing for Erk or Actin served as a loading control. The results shown are representative of at least 3 independent experiments.

Loss of the BH3-only protein Puma protects mast cells from apoptosis induced by cytokine deprivation. Survival of mast cells in the absence of cytokines was measured by staining with PI plus annexin V-FITC (A) MLMCs where ◇ indicates wild-type; ▵, Noxa−/−; ×, Bad−/−; and ○, Bid−/−. N = 4-12 (B) CTLMCs where ◇ indicates wild-type; ▵, Noxa−/−; ×, Bad−/−; ○, Bid−/−; and □, Bmf−/−. N = 2-6 (C) MLMCs where ◇ indicates wild-type; −, vav-Bcl2; ●, Puma−/−; ▴, Puma+/−. N = 6 (D) CTLMCs where ◇ indicates wild-type; −, vav-Bcl2; ●, Puma−/−; ▴, Puma+/−. N = 3-4 and results are presented as mean (± SD). (E) Expression of Puma was determined by Western blotting of lysates from wt MLMCs and CTLMCs following cytokine deprivation for 10 hours. Probing for Erk or Actin served as a loading control. The results shown are representative of at least 3 independent experiments.

Close Modal

or Create an Account

Close Modal
Close Modal